Center for Tropical and Emerging Global Diseases
University of Georgia
by Donna Huber Vaccines can be an efficient and cost-effective method of preventing and treating pathogen-induced illnesses. As new pathogens appear and old pathogens re-emerge, improved vaccines are needed. For one emerging global disease, Chagas Disease, effective vaccine development has long been elusive. Now, Rick Tarleton, Regents’ Professor in the department of cellular biology, and former …
Abstract Trypanosoma cruzi infection is characterized by chronic parasitism of non-lymphoid tissues and is rarely eliminated despite potent adaptive immune responses. This failure to cure has frequently been attributed to a loss or impairment of anti-T. cruzi T cell responses over time, analogous to the T cell dysfunction described for other persistent infections. In this study, we have …
Researchers at the University of Georgia have discovered that dormancy of the parasite Trypanosoma cruzi prevents effective drug treatment for Chagas disease, which kills more than 50,000 people each year in Central and South America and is a growing threat in the United States and Europe. The disease infects an estimated 6 million to 7 million …
NIH T32 trainee Molly Bunkofse, a Ph.D. student in Rick Tarleton‘s laboratory, is originally from Illinois and I obtained my BA in Biology from a small, liberal arts college called Augustana, which is located in Rock Island, IL. Molly’s research focus Molly’s project focuses on the host CD8+ T cell response that is generated against …
Athens, Ga. – Rick Tarleton, Distinguished Research Professor and University of georgia Athletic Association Distinguished Professor in Biological Sciences in the Franklin College of Arts and Sciences, has been named Regents’ Professor, effective July 1. Regents’ Professorships are bestowed by the University System of Georgia’s Board of Regents on faculty members whose scholarship or creative …
